Home » Topics » Regulatory » EMA

EMA
RSS

BioAlliance gives update on Livatag and Clonidine Lauriad

July 14, 2011

Advanced Cell Technology's RPE cells gain E.U. orphan drug status in Stargardt's macular dystrophy

July 7, 2011

CHMP adopts positive opinion on new Kiovig indication in multifocal motor neuropathy

July 1, 2011

CHMP recommends approval of Eurartesim for malaria

June 30, 2011

EMA accepts tesamorelin MAA for review

June 29, 2011

Amgen obtains positive CHMP opinion on Vectibix after reexamination

June 29, 2011

CHMP adopts positive opinion on Buccolam

June 29, 2011

CHMP issues negative opinion on Bronchitol for cystic fibrosis

June 28, 2011

CHMP issues negative opinion on Glybera MAA

June 28, 2011

EMA continues review of pioglitazone-based medicines

June 28, 2011

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 30, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 30, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...